Tarsus Pharmaceuticals, Inc.
TARS
Rang în acțiuni
#4560
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.
Preț acțiune
$70.82
Ultima sincronizare: 2026-10-21
Capitalizare de piață
$3.31B
Schimbare (1 zi)
-0.30%
Schimbare (1 an)
3.08%
Țară
US
Tranzacționează Tarsus Pharmaceuticals, Inc. (TARS)
Categorie
Healthcare
Istoric al prețului acțiunii pentru Tarsus Pharmaceuticals, Inc. (TARS)
Cel mai mare preț de închidere: $72.26 pe 2026-10-01
Cel mai mic preț de închidere: $21.51 pe 2020-10-01
Cel mai mic preț de închidere: $21.51 pe 2020-10-01
Istoric al prețului acțiunii pentru Tarsus Pharmaceuticals, Inc. din 2020 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2026 (TTM) | -13.75% |
| 2025 | 54.26% |
| 2024 | 182.67% |
| 2023 | 21.69% |
| 2022 | -38.83% |
| 2021 | -32.39% |
| 2020 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $760.15 | 8.04% |
CH
|
